Summarized by Masters of Longevity from Longevity Technology.
Eisai and Biogen launched a subcutaneous Leqembi pen in Japan with reimbursement.

Key Takeaways
- Eisai and Biogen launched the Leqembi Pen on November 12, 2026.
- Japan approved the subcutaneous formulation on September 16, 2026.
- The pen was added to Japan's National Health Insurance drug list.



